Skip to main content

and
  1. Article

    Open Access

    Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity

    Approximately 15–30% of patients with lung cancer harbor mutations in the EGFR gene. Major EGFR mutations (>90% of EGFR-mutated lung cancer) are highly sensitive to EGFR tyrosine kinase inhibitors (TKIs). Many un...

    Takahiro Yoshizawa, Ken Uchibori, Mitsugu Araki in npj Precision Oncology (2021)